Pharma News

For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising superpower—the ability to fight off all viruses. Columbia immunologist Dusan Bogunovic discovered the individuals’ antiviral powers about 15 years ago, soon after he identified the genetic mutation that causes the condition.

A new study has shed light on how a type of drug works to reduce liver damage in alcohol-related liver disease, by reshaping the architecture of the tissue. The findings could pave the way for the development of new treatments for liver disease and improve outcomes for patients.

The Government of India is accelerating its efforts to reduce dependence on pharmaceutical imports and strengthen domestic capabilities, with the Department of Pharmaceuticals rolling out key initiatives and reporting remarkable progress under flagship schemes.

Novo Nordisk has reported the theft of multiple batches of its critical injectable drug products during transit from its Bhiwandi Hub to destinations on the milk route covering Nagpur, Raipur, Cuttack, and Kolkata.

A new study from the University of Florida is shedding light on what could become a game-changing approach in cancer treatment: a universal mRNA vaccine designed to awaken the immune system against tumors.

Over the past few years, Department of Atomic Energy (DAE) has developed several key nuclear medicine ligands and targeted therapeutics towards national effort against cancer, especially in the areas of advanced treatment and research. To cater the demand for import substitute radiation-medicine in India, Department of Atomic Energy

Nearly a quarter of people over the age of 40 experience painful osteoarthritis, making it a leading cause of disability in adults. Osteoarthritis degrades joint-cushioning cartilage, and there is currently no way of reversing this damage: the only option is to manage pain with medication, and eventually, joint replacement.

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer, one of the most aggressive and hard-to-treat forms of breast cancer.

Vanda Pharmaceuticals Inc. (Vanda) announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its longstanding dispute with the agency regarding the approvability of HETLIOZ® (tasimelteon) to treat jet lag disorder